Suche ›

Renal Cell Carcinoma

Molecular Targets and Clinical Applications

Springer New York,
160,49 € Lieferbar in 5-7 Tagen
Dieses Produkt ist auch verfügbar als:


The third edition of this critically acclaimed book has updated and expanded the survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. Internationally renowned editors and contributors explore the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors.Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Third Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by leaders of the field.


Titel: Renal Cell Carcinoma
Autoren/Herausgeber: Ronald Bukowski, Robert A. Figlin, Robert Motzer (Hrsg.)
Ausgabe: 3., Softcover reprint of the original 3rd ed. 2015

ISBN/EAN: 9781493950638

Seitenzahl: 613
Format: 23,5 x 15,5 cm
Produktform: Taschenbuch/Softcover
Gewicht: 955 g
Sprache: Englisch

Ronald M Bukowski MDEmeritus Staff PhysicianCleveland Clinic Taussig Cancer CenterProfessor Emeritus of MedicineCCF Lerner College of Medicine of CWRURobert Figlin MDProfessor of Medicine and Biomedical SciencesDirector, Division of Hematology OncologyDepartment of Medicine, Cedars-Sinai Medical CenterAssociate Director for Academic ProgramsSamuel Oschin Comprehensive Cancer InstituteProfessor Emeritus of Medicine and UrologyDavid Geffen School of Medicine at UCLARobert Motzer MDAttending PhysicianDepartment of MedicineMemorial Sloan-Kettering Cancer CenterProfessor of MedicineWeil Medical College of Cornell University - Newsletter
Möchten Sie sich für den Newsletter anmelden?

Bitte geben Sie eine gültige E-Mail-Adresse ein.
Lieber nicht